DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Gershanovich M, Chaudri HA, Campos D, Lurie H, Bonaventura A, Jeffrey M. et al.
Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2. 5 mg daily, 0. 5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer.
Ann Oncol 1998; 9: 639-645
We do not assume any responsibility for the contents of the web pages of other providers.